Home »
Welcome: Login | Register

Medical Device Industry News

MassDevice.com +7 | The top 7 med-tech stories for the week of May 20, 2013

May 24, 2013 by Arezu Sarvestani

If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

News Well, Plus 7

The FDA: Now more popular than the IRS, Federal Reserve and Dept. of Homeland Security

May 24, 2013 by Brian Johnson

A new Gallup poll shows that American's opinion of the FDA is on the upswing

American's view of the FDA are improving, according to a recent Gallup survey of opinions on federal agencies.

The federal watchdog agency received a net positive rating of 24%, according to the polling organization, putting it ahead of The Department of Homeland Security, Federal Reserve, Environmental Protection Agency and the Internal Revenue Service.

News Well, Food & Drug Administration (FDA)

EuroPCR: Medtronic moving forward with its renal denervation study

May 24, 2013 by Sony Salzman

Medtronic finishes enrolling patients in a U.S. trial of its Simplicity renal denervation system to treat high blood pressure

Medtronic

Medtronic (NYSE:MDT) has wrapped up patient enrollment in its Symplicity HTN-3 trial to evaluate company's renal denervation system and support U.S. approval.

News Well, Catheters, EuroPCR, Renal

EuroPCR: St. Jude's EnligHTN device shows promising 1-year trial results

May 24, 2013 by Sony Salzman

St. Jude presents 1-year data supporting its EnligHTN device for patients with drug-resistant high blood pressure


StJude

St. Jude Medical (NYSE:STJ) released results for its EnligHTN renal denervation system trial, which effectively lowered blood pressure in patients after 1 year.

Data from EnliGHTN I was presented at the annual EuroPCR meeting in Paris, France.

News Well, Clinical Trials, Catheters, EuroPCR

EuroPCR: Volcano, Boston Scientific team up for accurate stent placement study

May 24, 2013 by Sony Salzman

Volcano and Boston Scientific use their respective devices simultaneously for more accurate stent placement in a new study announced at EuroPCR

EuroPCR

Volcano Corporation (NSDQ:VOLC) and Boston Scientific (NYSE:BSX) announced a new, cosponsored Syntax study to test precision in stent placement.

The companies announced the upcoming study at the EuroPCR annual meeting in Paris, France.

News Well, Clinical Trials, EuroPCR, stent

Legal: Intuitive Surgical wins jury trial in da Vinci training claim

May 24, 2013 by Sony Salzman

Jurors in Washington state vote 10-2 for Intuitive Surgical in the first of many lawsuits over the company's da Vinci robotic surgical system

IntuitiveSurgical

Intuitive Surgical (NSDQ:ISRG) won a legal victory in a patient injury lawsuit involving its da Vinci robotic surgical assist device.

Legal News, News Well, Personal Injury, Robot-Assisted Surgery

FzioMed's post-surgical gel lands a regulatory win in Australia

May 24, 2013 by Sony Salzman

Aussie regulators give the green light to FizioMed's Dynavisc, an absorbable gel applied to tendons and nerves after surgery.

FzioMed

Privately held medical device maker FzioMed won Australian regulatory approval for its Dynavisc post-surgical gel, an absorbable gel applied to tendons and nerves to reduce adverse events after surgery.

The San Luis Obispo, Calif.-based company said the product is similar to Medtronic's (NYSE:MDT) Medishield, which has been on the market for more than 70 years.

News Well, Regulatory/Clearance, Surgical
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp